Talanx, DE000TLX1005

BNP Paribas downgraded Talanx stock to Neutral

Published on 10/08/2026 at 12:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half net income reached EUR 1.50 billion, up 9.00 percent. Talanx stock costs EUR 119.40 versus EUR 119.50.

Isometrische 3D-Grafik einer Versicherungs-Wertschöpfungskette mit Häusern, Autos und Figuren
Talanx AG (DE000TLX1005) dargestellt als isometrisches 3D-Diagramm der Wertschöpfungskette von Risikoprüfung bis Schadensauszahlung, Illustration mit AI erstellt.

Talanx (ISIN DE000TLX1005) was trading at EUR 119.40 at Lang & Schwarz on October 8, 2026, while BNP Paribas had downgraded the insurer from Outperform to Neutral with a EUR 120.00 target on September 8, 2026. The downgrade followed a 23.00 percent rally cited by Investing.com, making valuation and claims trends the key counterweight to the insurer's strong earnings trajectory.

BNP Paribas sets a cautious counterpoint

Investing.com reported that BNP Paribas cut its Talanx rating to Neutral on September 8, 2026, from Outperform, and assigned a EUR 120.00 target. The target is only EUR 0.60 above the Lang & Schwarz price, so the published stance points to limited near-term valuation headroom rather than a broad earnings challenge.

The same report said four of seven analysts rated Talanx Buy, while the average target stood at EUR 128.43 on October 1, 2026. That average was EUR 9.03 above the Lang & Schwarz price, but the range from EUR 94.00 to EUR 163.00 shows a wide spread in expectations.

Record half-year supports the earnings case

Talanx delivered a stronger operating backdrop in the first half of 2026. According to Investing.com, net income rose 9.00 percent year over year to EUR 1.50 billion, while insurance revenue reached EUR 24.30 billion. Large claims totaled EUR 942.00 million against a planned EUR 1.42 billion, a difference of EUR 478.00 million that supported the result.

The report also said Talanx expected 2026 net income of more than EUR 2.70 billion and a return on equity of 19.00 percent. Those figures keep the profit outlook central, while BNP Paribas' September downgrade highlights the risk that a large part of the earnings improvement is already reflected in the share price.

November report sets the next test

Talanx has scheduled its quarterly or interim statement for November 12, 2026. The date was published by EQS News on October 6, 2026. The release will give investors a fresh check on claims, revenue and progress toward the more than EUR 2.70 billion full-year net income outlook.

Stock stays below its yearly high

Talanx stock was trading at EUR 119.40 at Lang & Schwarz on October 8, 2026 at 12:10 p.m. CEST, minus 0.08 percent versus the Xetra close of EUR 119.50 on October 7, 2026. Its EUR 97.65 to EUR 128.80 52-week range places the current price EUR 9.40 below the high and EUR 21.75 above the low, while market capitalization stood at EUR 30.9 billion as of October 8, 2026. The further course of trading is shown by the continuously updated real-time quote of Talanx stock.

Talanx stock facts

  • Company: Talanx AG
  • ISIN: DE000TLX1005
  • WKN: TLX100
  • Ticker: TLX
  • Primary exchange: Xetra
  • Price Lang & Schwarz as of October 8, 2026, 12:10 p.m. CEST: EUR 119.40
  • Change versus Xetra close: minus 0.08 percent
  • Xetra close October 7, 2026: EUR 119.50
  • Market capitalization: EUR 30.9 billion as of October 8, 2026
  • 52-week range: EUR 97.65-EUR 128.80 as of October 8, 2026
  • Sector / Industry: Financials / Insurance
  • Index membership: MDAX
  • Next earnings date: November 12, 2026

More news and analyses on Talanx stock

Disclaimer...

en | DE000TLX1005 | TALANX | boerse | 70265253 | bgmi